BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK
LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments, including Gas Endeavour® III systems, with a combined value of approximately 0.7 MSEK.
CEO Dr. Jing Liu comments: "We are pleased to receive a significant order from a globally recognised research institution. KU Leuven's decision to transition to our technology confirms the value and reliability of our instruments in advanced scientific applications."
BPC has received orders from university KU Leuven in Belgium. The value of the orders amounts to approximately 0.7 MSEK and includes several instruments including Gas Endeavour® III. The university is replacing and upgrading its setup for biochemical methane potential (BMP) testing with BPC's instruments for both batch and continuous measurements. The new systems are expected to streamline workflows and provide more precise and reliable data in research related to biological and biochemical gas processes. Revenue from these orders is expected to be recognised in Q2 2025.
About Gas Endeavour® III
Gas Endeavour® III is an advanced laboratory instrument platform designed for precise evaluation of gas production or consumption measurements in both batch and continuous processes. With its fully automated operation, an intuitive user interface, and high reliability, it offers exceptional ease of use. The system is available with 18 or 9 parallel channels, allowing for the simultaneous evaluation of multiple samples. For more information about Gas Endeavour® III, visit the Gas Endeavour® III product page or contact the sales team at sales@bpcinstruments.com.
For more information, please contact:
Dr. Jing Liu, CEOBPC Instruments AB Tel: +46 (0) 46 16 39 51 E-mail: ir@bpcinstruments.com
About BPC Instruments AB
BPC Instruments is a global Swedish-based pioneering technology company developing and offering analytical instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing analysis. BPC Instruments' innovative products offer high-quality hardware and software based on deep knowledge and experience of target applications. The solutions are the first of their kind, making the company a pioneer in its field. Today, BPC Instruments exports to nearly 80 countries around the world. BPC is listed on the Spotlight Stock Market in Sweden. For more information, please visit BPC's webpage: www.bpcinstruments.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/bpc-instruments-ab/r/bpc-instruments-receives-orders-from-ku-leuven-valued-at-0-7-msek,c4159015
The following files are available for download:
https://mb.cision.com/Main/21129/4159015/3486823.pdf
Press release - KU Leuven
View original content:https://www.prnewswire.co.uk/news-releases/bpc-instruments-receives-orders-from-ku-leuven-valued-at-0-7-msek-302473073.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Using AI bots like ChatGPTcould be causing cognitive decline, new study shows
A new pre-print study from the US-based Massachusetts Institute of Technology (MIT) found that using OpenAI's ChatGPT could lead to cognitive decline. Researchers with the MIT Media lab broke participants into three groups and asked them to write essays only using ChatGPT, a search engine, or using no tools. Brain scans were taken during the essay writing with an electroencephalogram (EEG) during the task. Then, the essays were evaluated by both humans and artificial intelligence (AI) tools. The study showed that the ChatGPT-only group had the lowest neural activation in parts of the brain and had a hard time recalling or recognising their writing. The brain-only group that used no technology was the most engaged, showing both cognitive engagement and memory retention. Related Can ChatGPT be an alternative to psychotherapy and help with emotional growth? The researchers then did a second session where the ChatGPT group were asked to do the task without assistance. In that session, those who used ChatGPT in the first group performed worse than their peers with writing that was 'biased and superficial'. The study found that repeated GPT use can come with 'cognitive debt' that reduces long-term learning performance in independent thinking. In the long run, people with cognitive debt could be more susceptible to 'diminished critical inquiry, increased vulnerability to manipulation and decreased creativity,' as well as a 'likely decrease' in learning skills. 'When participants reproduce suggestions without evaluating their accuracy or relevance, they not only forfeit ownership of the ideas but also risk internalising shallow or biased perspectives,' the study continued. Related 'Our GPUs are melting': OpenAI puts restrictions on new ChatGPT image generation tool The study also found higher rates of satisfaction and brain connectivity in the participants who wrote all essays with just their minds compared to the other groups. Those from the other groups felt less connected to their writing and were not able to provide a quote from their essays when asked to by the researchers. The authors recommend that more studies be done about how any AI tool impacts the brain 'before LLMs are recognised as something that is net positive for humans.'
Yahoo
7 hours ago
- Yahoo
Top Research Reports for Meta Platforms, Palantir & Abbott
Friday, June 20, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Palantir Technologies Inc. (PLTR) and Abbott Laboratories (ABT), as well as two micro-cap stocks SandRidge Energy, Inc. (SD) and CompX International Inc. (CIX). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the research reports have been hand-picked from the roughly 70 reports published by our analyst team can see all of today's research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each can read today's AWS here >>> Pre-Markets Climb on Rate Cut VisibilityToday's Featured Research ReportsMeta Platforms' shares have outperformed the Zacks Internet - Software industry over the past year (+39.2% vs. +37.1%). The company is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its offerings like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver. META has been leveraging AI to improve the potency of its offerings. These services currently reach more than 3.43 billion people daily. Meta Platforms' growing footprint among young adults, driven by improving recommendations, boosts its competitive prowess. AI usage is making it a popular name among advertisers. This is expected to drive top-line growth. Meta Platforms now expects to invest significantly more over the next few years in developing more advanced models and the largest AI services in the world. However, monetization of these AI services will take considerable time, which is a concern.(You can read the full research report on Meta Platforms here >>>)Shares of Palantir have outperformed the Zacks Internet - Software industry over the year-to-date period (+85% vs. +13%). The company's AI strategy, driven by Foundry, Gotham and AIP platforms, targets government and commercial sectors, enabling real-time insights and operational efficiency. Notable defense projects like Open DAGIR, and AIP boot camps for commercial clients boost customer acquisition. With $5.2 billion in cash, no debt and S&P 500 inclusion, Palantir enjoys strong liquidity, growing revenues and increased investor visibility. However, PLTR's reluctance to pay quarterly dividends is a minus for dividend-seeking investors. Intense competition from tech giants and rising costs amidst a rapidly evolving AI landscape and an elevated valuation also challenge its appeal. (You can read the full research report on Palantir here >>>)Abbott's shares have outperformed the Zacks Medical - Products industry over the past year (+27.8% vs. +8.9%). The company's pipeline is unlocking new growth opportunities, supporting the company's positive momentum and strong growth outlook for 2025. Freestyle Libre, Lingo and Libre Rio CGM devices are on a great the company's next-generation suite of systems, is a key driver in the core lab diagnostics business. Abbott is optimistic about its latest progress with biosimilars and expects this to significantly boost EPD sales, beginning 2025. Within Nutrition, despite softness in international pediatric arm, Abbott is regaining market share banking on strong Adult Nutrition business. Yet, the significant runoff of COVID-19 testing-related sales is hurting Abbott's Diagnostics growth. Headwinds such as tough macro conditions and foreign exchange also adds to the worry. (You can read the full research report on Abbott here >>>)Shares of SandRidge Energy have outperformed the Zacks Oil and Gas - Integrated - U.S. industry over the year-to-date period (+5.3% vs. -1.6%). This microcap company with a market capitalization of $443.18 million has a debt-free balance sheet and $101.1 million cash position back strong self-funding capacity, and $13.6 million in free cash flow in Q1 2025. Adjusted EBITDA jumped 73% to $25.5 million on higher volumes and better gas prices, with gas now 49% of production. Since 2023, $158 million has been returned to shareholders via dividends and buybacks, with $70 million repurchase capacity remaining. Cherokee drilling supports reserve growth, but capital intensity and WTI/gas price volatility pose risks. Heavy back-half completions, cost inflation, and natural gas legacy underutilization limit efficiency. Large NOLs support tax sheltering but rely on consistent profits; Section 382 limits apply. Reserve quality hinges on Cherokee execution as legacy reserves decline. Commodity swings and execution missteps could pressure cash flow and returns despite strong capital discipline.(You can read the full research report on SandRidge Energy here >>>)CompX International's shares have outperformed the Zacks Office Supplies industry over the past year (+18.8% vs. -38%). This microcap company with a market capitalization of $293.43 million has first-quarter 2025 results highlight resilient core operations and expanding profitability. Security Products maintained a stable gross margin (29.8%) despite OEM softness, supported by gains in government and healthcare markets. Marine Components delivered a 24% year-over-year sales increase and a structural margin uplift to 22.3%, driven by fixed cost leverage and a favorable product mix. The company-wide gross margin rose to 30.2%, fueling a 58% surge in operating income. Cash remained strong at $56.1 million, with no debt and improved inventory efficiency. However, risks include negative operating cash flow due to rising receivables, a 29% drop in interest income and tariff-driven raw material inflation. Continued OEM channel weakness and DSO expansion raise caution, but internal execution and margin tailwinds position CompX for an upside in 2025.(You can read the full research report on CompX International here >>>)Other noteworthy reports we are featuring today include Intuit Inc. (INTU), Illinois Tool Works Inc. (ITW) and Veeva Systems Inc. (VEEV).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Expanding AI Usage Drives Meta Platforms' (META) Prospects Modular Sales Tactic Aids Palantir (PLTR), Competition High Solid EPD Prospects, CGM Leadership Boosts Abbott (ABT) Featured Reports Food Equipment Unit Aids Illinois Tool (ITW) Amid Forex WoesPer the Zacks analyst, Illinois Tool is benefitting from its Food Equipment unit, driven by strength in the institutional end markets in North America. However, forex woes are an added concern. Ross' (ROST) Strong Demand Trends Aid Sales, Tariff Woes HurtPer the Zacks analyst, Ross Stores' sales benefits from ongoing strength in consumer demand. But ongoing macroeconomic and geopolitical uncertainty, including tariff woes, raise investor concerns. Investments Aids PG&E Corporation (PCG) Amid Poor SolvencyPer the Zacks analyst, PG&E makes systematic investments to maintain and upgrade the reliability of its infrastructure. Yet its poor financial ratios indicate weak solvency position. Woodward (WWD) Boosted by Aerospace & Industrial StrengthPer the Zacks analyst, Woodward's strong Aerospace and Core Industrial units are driving growth, amid challenges from China's on-highway natural-gas truck market and Aerospace supply-chain issues. Season Pass Aids Vail Resorts (MTN) Amid Weak VisitationPer the Zacks analyst, Vail Resorts benefits from a stable season pass program and offerings such as the Epic Pass, Epic Day Pass, and Epic Australia Pass. However, weak visitation is a concern. AUM Growth Aids Main Street (MAIN), Rising Costs a DragPer the Zacks analyst, Main Street's robust asset under management (AUM) and strong liquidity back growth. However, increased expenses due to expansion may hurt profitability. Immunovant Bets on IMVT-1402 Amid Intense CompetitionPer the Zacks Analyst, IMVT-1402 could become a best-in-class medication for several autoimmune indications. However, significant competition in the market remains a worry. New Upgrades Intuit (INTU) Rides on Product Refresh, Higher SubscriptionsPer the Zacks analyst, Intuit is benefiting from frequent product refreshes, which help it to gain customers. Moreover, increase in subscriptions is driving stable revenue growth for the company. Veeva Systems (VEEV) Gains on Solid R&D, Strategic AlliancesPer the Zacks analyst, Veeva Systems is gaining from strong customer adoption and strategic alliances. Innovation, a solid product portfolio, and a debt-free balance sheet are also fueling growth. Increase in New Insurance Written Aid MGIC Investment (MTG)Per the Zacks analyst, MGIC Investment is poised to grow on higher insurance in force, improved direct premium yield, higher annual persistency, lower claims and a strong capital position. New Downgrades Helmerich & Payne (HP) Risks from Falling U.S. Rig DemandThe Zacks analyst believes that Helmerich & Payne's strong dependence on U.S. drilling puts it at risk of lower rig demand and weaker margins if oil prices continue falling. Campbell's (CPB) Appears Troubled by Elevated Cost InflationPer the Zacks analyst, cost inflation hurt Campbell's gross margin. In Q3 adjusted gross profit margin fell 110 basis points to 30.1%, impacted by cost inflation and supply-chain costs among others. Soft Industrial Demand, Repositioning Ail Ingevity (NGVT)According to the Zacks analyst, Ingevity faces headwinds from weaker industrial demand. Its repositioning measures will also hurt sales in the industrial specialties product line. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report Abbott Laboratories (ABT) : Free Stock Analysis Report Intuit Inc. (INTU) : Free Stock Analysis Report SandRidge Energy, Inc. (SD) : Free Stock Analysis Report CompX International Inc. (CIX) : Free Stock Analysis Report Veeva Systems Inc. (VEEV) : Free Stock Analysis Report Palantir Technologies Inc. (PLTR) : Free Stock Analysis Report Meta Platforms, Inc. (META) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
9 hours ago
- Yahoo
Apple Hardware Executive Says iPhone Maker Plans To Use AI For Speeding Up Custom Chip Design: 'High Potential In Getting More Design Work In Less Time'
Apple Inc. (NASDAQ:AAPL) is reportedly looking to harness the power of generative artificial intelligence to accelerate the development of the custom chips that power its devices, according to senior executive Johny Srouji. What Happened: During a speech in Belgium last month, Apple's senior vice president of hardware technologies, Srouji, said the company is exploring generative AI to streamline chip design, calling it a major productivity opportunity, reported Reuters on Wednesday. "Generative AI techniques have a high potential in getting more design work in less time, and it can be a huge productivity boost," Srouji said, according to a recording reviewed by the publication. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share. Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share. He made the remarks while accepting an award from Imec, a prominent semiconductor R&D organization. During his speech, Srouji highlighted that electronic design automation (EDA) firms like Cadence Design Systems (NASDAQ:CDNS) and Synopsys Inc. (NASDAQ:SNPS)—both racing to integrate AI—are critical to managing the complexity of Apple's chip development. Srouji also reflected on Apple's bold move in 2020 to replace Intel Corp (NASDAQ:INTC) chips in Mac computers with its own Apple Silicon. He said that it was a major takeaway from Apple's chip development journey was the importance of making bold decisions and moving forward without hesitation. "There was no backup plan, no split-the-lineup plan, so we went all in," he said. "Including a monumental software effort." Why It's Important: Last month, it was reported that Apple is developing new chips to power upcoming smart glasses, AI servers and future Macs. Apple aims to launch it by 2026–2027. Meanwhile, the M5 chip, built on the advanced 3nm N3P architecture, has reportedly entered mass production and is expected to enhance the MacBook Pro, iPad Pro and Vision Pro—especially with upcoming Apple Intelligence features. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo Courtesy: Prathmesh T on UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Apple Hardware Executive Says iPhone Maker Plans To Use AI For Speeding Up Custom Chip Design: 'High Potential In Getting More Design Work In Less Time' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
